Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor

被引:0
作者
Gerben J. C. Zwezerijnen
Jakoba J. Eertink
Maria C. Ferrández
Sanne E. Wiegers
Coreline N. Burggraaff
Pieternella J. Lugtenburg
Martijn W. Heymans
Henrica C. W. de Vet
Josée M. Zijlstra
Ronald Boellaard
机构
[1] Amsterdam UMC Location Vrije Universiteit Amsterdam,Radiology and Nuclear Medicine
[2] Cancer Center Amsterdam,Epidemiology and Data Science
[3] Imaging and Biomarkers,undefined
[4] Amsterdam UMC Location Vrije Universiteit Amsterdam,undefined
[5] Erasmus MC Cancer Institute,undefined
[6] University Medical Center,undefined
[7] Amsterdam UMC Location Vrije Universiteit Amsterdam,undefined
[8] Amsterdam Public Health Research Institute,undefined
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2023年 / 50卷
关键词
Liver uptake; Reference; VOI; [18F]FDG PET/CT;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:486 / 493
页数:7
相关论文
共 66 条
[1]  
Barrington SF(2014)Role of imaging in the staging and response assessment of lymphoma consensus of the International Conference On Malignant Lymphomas Imaging Working Group J Clin Oncol Official J Am Soc Clin Oncol 32 3048-3058
[2]  
Aide N(2017)EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies Eur J Nucl Med Mol Imaging 44 17-31
[3]  
Eertink JJ(2022)(18)F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma Eur J Nucl Med Mol Imaging 49 932-942
[4]  
Kido H(2021)The metabolic parameters based on volume in PET/CT are associated with clinicopathological N stage of colorectal cancer and can predict prognosis EJNMMI Res 11 87-87
[5]  
Boellaard R(2019)Updating PET/CT performance standards and PET/CT interpretation criteria should go hand in hand EJNMMI Res 9 95-95
[6]  
Boellaard R(2015)FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 Eur J Nucl Med Mol Imaging 42 328-54
[7]  
Vali R(2021)SNMMI Procedure Standard/EANM Practice Guideline on Pediatric (18)F-FDG PET/CT for Oncology 1.0 J Nucl Med 62 99-110
[8]  
Eertink JJ(2021)Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients Blood Adv 5 2375-2384
[9]  
Ilyas H(2018)Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma Eur J Nucl Med Mol Imaging 45 1142-1154
[10]  
Wahl RL(2009)From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors J Nucl Med 50 Suppl 1 122s-50s